Actavis Elizabeth LLC v. Novartis Pharmaceuticals Corporation > Summary
Court Case Number IPR2017-01946
Filing Date Aug 15, 2017
Institution Decision Date Sep 11, 2017
Decision Date Aug 7, 2018
Court Patent Trial and Appeal Board
Status FWD Entered
Appeal2018-2209
Administrative JudgesRobert A. Pollock, Lora M. Green, Christopher M. Kaiser
Judge Writing the Final DecisionRobert A. Pollock
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6
Claims Instituted: 1, 2, 3, 4, 5, 6
Petitioner
Patent Owner
Petitioner Attorneys
12Actavis Elizabeth (Teva)
Attorney Name: Amanda Hollis
Kirkland & Ellis
Actavis Elizabeth (Teva)
Attorney Name: Eugene Goryunov
Kirkland & Ellis
Actavis Elizabeth (Teva)
Attorney Name: Teresa Stanek Rea
Crowell & Moring
Actavis Elizabeth (Teva)
Attorney Name: Deborah H. Yellin
Crowell & Moring
Actavis Elizabeth (Teva)
Attorney Name: Shannon M. Lentz
Crowell & Moring
Actavis Elizabeth (Teva)
Attorney Name: Tyler C. Liu
Argentum Pharmaceuticals
Actavis Elizabeth (Teva)
Attorney Name: Steven W. Parmelee
Wilson Sonsini Goodrich & Rosati
Actavis Elizabeth (Teva)
Attorney Name: Michael T. Rosato
Wilson Sonsini Goodrich & Rosati
Actavis Elizabeth (Teva)
Attorney Name: Jad Allen Mills
Wilson Sonsini Goodrich & Rosati
Actavis Elizabeth (Teva)
Attorney Name: Gregory R. Springsted
Kirkland & Ellis
Actavis Elizabeth (Teva)
Attorney Name: Samuel S. Park
Winston & Strawn
Apotex
Attorney Name: Barbara S. Giesser
The Regents of the University of California
Patent Owner Attorneys
2Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Novartis
Attorney Name: Robert W. Trenchard
Gibson Dunn & Crutcher
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 09187405 | S1P receptor modulators for treating relasping-remitting multiple sclerosis | Nov 17, 2015 |
